Future prospects for anti-cytokine treatment

The era of anti-cytokine treatment in rheumatology has just begun. The firs t generation therapeutic agents, biological agents that block tumour necros is factor a such as monoclonal antibodies or receptor Ig fusion proteins ar e safe and effective, and so this has generated much interest in how to inc rease the benefit or deliver it more cost effectively. This article provide s a personal view of the coming trends in anti-cytokine treatment. Which of these will be realised in the future will be of interest.